Detalles de la búsqueda
1.
AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group study.
Acta Oncol
; 60(6): 785-793, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34003074
2.
An MRI study of immune checkpoint inhibitor-induced musculoskeletal manifestations myofasciitis is the prominent imaging finding.
Rheumatology (Oxford)
; 59(5): 1041-1050, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32344435
3.
Whole body bone SPET/CT can successfully replace the conventional bone scan in breast cancer patients. A prospective study of 257 patients.
Hell J Nucl Med
; 21(2): 125-133, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30089314
4.
Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG).
World J Urol
; 34(6): 853-7, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26410826
5.
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer.
BMC Cancer
; 15: 384, 2015 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25956750
6.
Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells.
J Biomed Sci
; 22: 98, 2015 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26497899
7.
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).
BMC Cancer
; 14: 111, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24555920
8.
Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.
BMC Cancer
; 13: 263, 2013 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-23718900
9.
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
BMC Cancer
; 13: 49, 2013 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23374602
10.
Health-related quality of life in patients with solid tumors receiving implantable venous access ports for chemotherapy: A prospective randomized controlled trial.
Eur J Oncol Nurs
; 67: 102445, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37871414
11.
Small Extracellular Vesicles (sEVs) Biogenesis Molecular Players Are Associated with Clinical Outcome of Colorectal Cancer Patients.
Cancers (Basel)
; 15(6)2023 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980570
12.
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.
BMC Cancer
; 12: 271, 2012 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22748098
13.
Analysis of RANK-c interaction partners identifies TRAF3 as a critical regulator of breast cancer aggressiveness.
Neoplasia
; 33: 100836, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36095928
14.
Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study.
Ther Adv Med Oncol
; 14: 17588359221122728, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36105886
15.
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
BMC Med
; 9: 10, 2011 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-21281463
16.
Prolonged survival of neoplastic meningitis from breast cancer with letrozole and intrathecal methotrexate: a case report.
J Neurooncol
; 101(3): 509-11, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20563832
17.
RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs).
Genes (Basel)
; 12(11)2021 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34828291
18.
NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease development.
Transl Oncol
; 14(1): 100912, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33074124
19.
Genetic Variations of CD40 and LTßR Genes Are Associated With Increased Susceptibility and Clinical Outcome of Non-Small-Cell Carcinoma Patients.
Front Oncol
; 11: 721577, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34604057
20.
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.
BMC Med
; 8: 3, 2010 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-20055981